Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).

@article{Lansky2009ImpactOG,
  title={Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).},
  author={Alexandra J Lansky and Roxana Mehran and Ecatarina Cristea and Helen Parise and Frederick Feit and E Magnus Ohman and Harvey Douglas White and Karen P Alexander and Michel E. Bertrand and Walter J. Desmet and Mich{\`e}le Hamon and Gregg Whitney Stone},
  journal={The American journal of cardiology},
  year={2009},
  volume={103 9},
  pages={1196-203}
}
Women with non-ST-elevation acute coronary syndrome are at increased risk for ischemic and bleeding complications compared with men. We examined the impact of gender and antithrombotic therapy for non-ST-elevation acute coronary syndrome on outcomes in patients in the ACUITY trial. Patients were randomized to heparin (unfractionated or enoxaparin) plus a glycoprotein IIb/IIIa inhibitor (GPI), bivalirudin plus a GPI, or bivalirudin alone. We compared major bleeding unconnected to coronary artery… CONTINUE READING
22 Citations
25 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 22 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 25 references

Similar Papers

Loading similar papers…